Stocks to Watch Tomorrow , Tuesday, July 7 —–> Monday wrapped up with a set of crosscurrents that define exactly the kind of market Tuesday’s session will inherit. The ISM Services PMI registered 54 percent in June — the 24th consecutive month in expansion territory — a decrease of just 0.5 percentage points from May’s figure of 54.5 percent. Benign. Supportive. Exactly the kind of number that keeps the Fed from panicking in either direction.

But the real fireworks weren’t in the macro data. They were in the tape. The semiconductor sector absorbed another brutal day. Biotech lit up on a binary event closing fast. And the broader market is making one thing very clear: the AI-chip trade is rotating, not dying — and Tuesday could be the session where the lines are redrawn.

📊 Monday, July 6 Recap — What Happened Before Tuesday Opens

The PHLX Semiconductor Index (SOX) is down nearly 7% today and over 12% over the past two days, with today looking like a clean break of the prior uptrend line and the technicals having shifted in favor of the bears. Whether the 50-day SMA provides support from here is Tuesday’s first big question for chip traders.

The Texas Stock Exchange (TXSE) Launched Today: The Dallas-based exchange, abbreviated as TXSE and tongue-in-cheek referred to as ‘Y’all Street,’ began trading on July 6 in specified test stocks. A new competitor to NYSE and Nasdaq. Small news today. Potentially significant over the next decade for listings.

📊 The ISM Data Wall — What Monday’s Services Print Tells Tuesday

The ISM Services PMI for June came in at 54.0 percent, slightly lower than the forecast of 54.2 percent, keeping the index in expansion territory for a 24th consecutive month.

Breaking down what matters inside the headline:

The two numbers that matter most for Tuesday’s tape are the Employment Index and the Prices Index. ISM chair Steve Miller noted that World Cup-related hiring in the U.S. likely contributed to the increase in the Employment Index, and that prices for oil-related products should ease off in the fall as progress in moving oil through the Strait of Hormuz continues. A services sector that’s hiring and paying lower input prices is the textbook “soft landing” narrative — and Tuesday’s equity market will be processing that data point as it positions ahead of one of the most watched Fed documents in years.

Stocks to Watch Tomorrow

💊 1. Vera Therapeutics (NASDAQ: VERA) — Tuesday Is the Day the FDA Votes

Monday Premarket Move: +6–9% | Stock Near 52-Week High | PDUFA Date: TOMORROW, July 7

Shares of Vera Therapeutics jumped 9% in premarket trading on Monday as investors turned bullish ahead of a key regulatory decision on the biotech firm’s lead investigational drug for an autoimmune kidney disease. The FDA is set to announce its decision on atacicept for IgA Nephropathy (IgAN).

The Drug, The Disease, The Stakes:

• Atacicept is an investigational soluble recombinant fusion protein designed to block both BAFF and APRIL — the two cytokines responsible for B-cell overactivation that drives IgAN (IgA Nephropathy), a progressive autoimmune kidney disease with no complete cure
• If approved, atacicept would be the first B-cell modulator targeting both BAFF and APRIL for IgAN adults — a first-in-class designation that carries significant commercial weight
• The ORIGIN 3 Phase 3 trial showed proteinuria reduction of up to 46% — a compelling result that met primary and key secondary endpoints
• If approved: patients self-administer a once-weekly injection at home via autoinjector — a key commercial advantage over infusion-based therapies
• The IgAN market was valued at $730 million in 2024 with a 30.5% CAGR — a fast-growing, underserved niche with room for a differentiated first-in-class entrant.

The Context Wall — Pricing, Competition, and Timelines:

The Binary Reality:

The market has already priced in significant optimism. Over the past 120 days, the stock has run up 104.9%, trading near its 52-week high. This surge leaves limited room for further upside on a positive approval, as the stock is already reflecting a high probability of success. Any disappointment or delay could trigger a sharp reversal.

• A Complete Response Letter (CRL) from the FDA — the “fail” scenario — could send VERA down 40–70% in a single session
• A full approval could push toward the $60 target one Stocktwits analyst cited, representing roughly 35% upside from current levels
• An accelerated approval (base case) is likely already priced in — watch for the label language and any restrictions

Bottom Line: VERA is Tuesday’s biggest single-stock catalyst. If you’re in, you know it’s a binary. If you’re watching, know that the window between market open and the FDA announcement (could arrive any time Tuesday) is highly volatile. Position sizing is everything.

🖥️ 2. Penguin Solutions (NASDAQ: PENG) — The AI Infrastructure Earnings Play After Tuesday’s Close

YTD Gain Before Chip Selloff: +252% | Last Week: −13%+ | Earnings: Tuesday After Close

Penguin Solutions is a lesser-known peer to industry heavyweights like Micron and SanDisk — an AI infrastructure and memory solutions provider that integrates hardware for data centers, designing and managing the servers, storage, and software stacks that large enterprises rely on.

What Tuesday’s Earnings Report Will Tell the Market:

• EPS estimate: $0.54/share (+15% YoY)
• Revenue estimate: $407.5 million (+26% YoY)
• Both figures reflect PENG’s positioning as a critical AI infrastructure integrator — not a chip manufacturer, but the layer between the chips and the enterprise customer
• Penguin was caught in Thursday’s broad AI and chip selloff, tumbling over 13% and breaking below its 21-day exponential moving average.

Why This Earnings Report Carries Extra Weight:

In the context of the semiconductor sector’s 12% two-day decline, PENG’s results will be read as a proxy for real AI infrastructure spending beyond the chip manufacturers themselves. If PENG beats on revenue and raises guidance, it will validate that the AI buildout is intact at the enterprise level regardless of stock market volatility. A miss — especially on revenue or guidance — would deepen concerns that the AI infrastructure trade is rolling over.

Technical Setup:

Watch for: Revenue guidance vs. estimates. Given the AI spending momentum confirmed by Micron’s $41.46B quarter, a raise would trigger a sharp recovery. An in-line print or miss would accelerate the sector rotation away from AI hardware.

🔑 3. The Chip Sector (SOX, SNDK, MU, NVDA) — Finding a Floor

The SOX appeared to find support around the 20-day Simple Moving Average previously, but that support is absent now. Whether you draw an uptrend line or use the 20-day SMA as a gauge of the uptrend, the technicals have shifted in favor of the bears. The index appears to be approaching its 50-day SMA, which could provide some support.

The Key Data Points:

• SOX: Down ~12% in just two trading days (July 2 + July 6)
• SNDK: Fell 13% to $1,765 on July 2, now threatening to close below the 21-day EMA for the first time since late March — a technical inflection point for the entire momentum trade
• KLAC: Dropped 11.51% on Monday; earnings approaching (next in the chip earnings cycle)
• NVDA: Also under pressure, approaching an intermediate-term trend line after a failed breakout attempt

Tuesday’s technical signals to watch:

• Does the SOX 50-day SMA hold on a closing basis?
• Does SNDK recover the 21-day EMA or confirm the breakdown?
• Does any chip name get a meaningful analyst upgrade or price target raise that could stabilize sentiment?

The bear case: The chip selloff was not random. The Meta cloud announcement (selling compute capacity) structurally changes the demand equation for CRWV and NBIS — and fears are radiating to chip suppliers. If that narrative deepens Tuesday, the 50-day SMA won’t hold.

The bull case: Micron’s quarter ($41.46B revenue, 84.9% gross margin, FQ4 guidance of $50B) remains one of the strongest corporate earnings prints in history. Memory demand from AI isn’t disappearing — a 12% sector pullback in 2 days is an overreaction, not a structural reversal.

🛫 4. Airlines — Benefiting From Oil’s Plunge With DAL on Friday

Transportation stocks have seen a strong influx of capital, propelling airline shares significantly higher. Delta Air Lines, for instance, is getting an added lift from the recent drop in oil prices.

Oil at ~$68/barrel (WTI) — down nearly 20% from its peak — is jet fuel’s best friend. Every $1 decline in crude saves the major airlines approximately $400M–$600M annually in fuel costs. Delta reports Friday, July 10, but the sector-wide rotation into airlines is happening now.

Airlines to Watch Tuesday:

• DAL (Delta Air Lines): Earnings Friday; positioning trade in play all week. Delta expects second-quarter fuel costs to surge by $2 billion year-over-year, though higher ticket prices and reduced flight capacity are projected to bolster operating results.
• UAL (United Airlines) and AAL (American Airlines): Sympathy plays in the same oil-decline, travel-demand narrative
• The JETS ETF is the sector-level proxy to watch

📅 Tuesday’s Full Economic and Earnings Calendar

The Big Overhang: Wednesday’s FOMC Minutes

Kevin Warsh’s first FOMC meeting as Fed Chair produced a statement of around 130 words — down from figures above 300 in recent meetings — with no forward guidance. Warsh said: “It’s a bit shorter, a bit simpler and it dispenses with some older language.”

At the June 17 meeting, the FOMC held the federal funds rate steady at 3.50%–3.75%, with the median federal funds rate forecast for 2026 implying potential for one rate hike before year-end. PCE inflation expectations were revised up to 3.6% for 2026 from a prior forecast of 2.7%.

The minutes arrive Wednesday. But markets will be pre-positioning on Tuesday — either buying defensives in case the minutes show hawkish bias, or adding growth/tech if the soft NFP print is likely to dominate the discussion. Tuesday afternoon could see sector rotation accelerate based on FOMC positioning bets.

🧭 Bottom Line for Tuesday, July 7

Three things define Tuesday’s session:

1. VERA’s FDA announcement — binary, could arrive at any point during the trading day. If approved, biotech gets a broader sentiment boost. If denied or CRL issued, it’s a sector setback.

2. PENG’s after-close earnings — the first AI infrastructure print since the chip correction began. Its guidance will either validate or concern the broader AI trade.

3. Chip sector technical resolution — the SOX 50-day SMA is the line. A hold builds the bounce case. A breach extends the rotation-out trade.

The priority watchlist: Stocks to Watch Tomorrow

• VERA: Binary — watch for FDA announcement
• PENG: After close — read the guidance
• SOX/SNDK/MU: Technical floor watch
• Airlines (DAL, UAL): Oil-decline beneficiaries in rotation
• FOMC pre-positioning: Defensives vs. growth ahead of Wednesday

Follow TNN for daily  stock market news and financial news today.

Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss. Biotech stocks like VERA carry binary FDA decision risk — approvals and rejections can move stocks 40–80% in a single session. Always complete independent due diligence prior to executing equity trades. Prices referenced reflect conditions as of July 6, 2026. Past performance is not indicative of future results.

Further Reading: Stocks to Watch Tomorrow

• ISM June 2026 Services PMI Official Release
• ISM June 2026 Manufacturing PMI Report
• Vera Therapeutics Investor Relations — Atacicept PDUFA
• Penguin Solutions Investor Relations
• Federal Reserve FOMC Calendar 2026
• Schwab Week Ahead — July 6, 2026
• RTT News FDA PDUFA Calendar
• FactSet Earnings Insight Q2 2026

About The Author

Kasia Davis

See author's posts